| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 58.535 | 61.528 | 62.017 | 60.554 | 62.078 | 32.339 | 16.042 |
| Total Income - EUR | - | - | - | 58.535 | 61.528 | 62.058 | 60.554 | 62.179 | 32.339 | 16.042 |
| Total Expenses - EUR | - | - | - | 26.852 | 31.332 | 37.710 | 35.497 | 37.922 | 27.280 | 14.135 |
| Gross Profit/Loss - EUR | - | - | - | 31.684 | 30.197 | 24.348 | 25.057 | 24.258 | 5.059 | 1.907 |
| Net Profit/Loss - EUR | - | - | - | 31.098 | 29.581 | 23.728 | 24.452 | 23.637 | 4.735 | 1.426 |
| Employees | - | - | - | 3 | 2 | 2 | 2 | 2 | 2 | 1 |
Check the financial reports for the company - Genmedpsy Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 548 | 348 | 155 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 31.828 | 31.294 | 25.755 | 26.618 | 25.938 | 7.094 | 4.171 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 7.257 | 27.286 | 23.171 | 24.047 | 23.192 | 5.994 | 3.245 |
| Cash | - | - | - | 24.571 | 4.008 | 2.583 | 2.571 | 2.747 | 1.100 | 926 |
| Shareholders Funds | - | - | - | 30.900 | 29.632 | 23.777 | 24.500 | 23.685 | 4.784 | 1.474 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 1.476 | 2.010 | 2.132 | 2.118 | 2.253 | 2.310 | 2.697 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Genmedpsy Srl